Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

Bullboard Posts

Comment by Steve888on Jun 20, 2016 3:59pm

57 Views

Post# 24981242

RE:Expected Strong Buy

Clearly this is the period to accumulate cheap shares at historical lows. Once the sellers are gone and any news comes out, the share price could explode.

SuperMoney wrote:
+2.8 million bids at 0.03 now, which is strong sign to buy in. Any news from the meeting will make ICO jumping up. In fact, rarely find a good stock like ICO, which have millions of cash/working capitals; excellent projects with great potentials and government grants; +3.5 million payment milestone; incoming results and data from ICO-008 and Ico-009; etc. Definitely strong buy as far as I can see. Cheers.

Bullboard Posts

Changing Europe’s dependency on HREE from China